Skip to main content
SpringerLink
Log in

Multiple Sclerosis and Brain Atrophy

  • Chapter
MRI Atlas of MS Lesions

  • 1777 Accesses

Abstract

Atrophy of the brain and spinal cord has been recognized as part of MS pathology for a long time. Several studies have demonstrated annual decrease in brain volume of MS patients, ranging from 0.6 to 1%, compared with 0.1 to 0.3% in the general population during the normal aging process (Comi et al. 2001; Rovaris et al. 2001; Hardmeier et al. 2003; Ge et al. 2000).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benedict RH, Weinstock-Guttman B, Fishman I et al (2004) Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 6:226–230

    Article  Google Scholar 

  2. Comi G, Rovaris M, Leocani L et al (2001) Clinical and MRI assessment of brain damage in MS. Neurol Sci 22(Suppl 2):S123–S127

    Article  PubMed  Google Scholar 

  3. Dastidar P, Heinonen T, Lehtimaki T et al (1999) Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis. J Neurol Sci 165:36–42

    Article  PubMed  CAS  Google Scholar 

  4. Fisher E, Rudick RA, Simon JH et al (2002) Eight-year follow-up study of brain atrophy in patients with MS. Neurology 59:1412–1420

    PubMed  CAS  Google Scholar 

  5. Ge Y, Grossman RI, Udupa JK et al (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214:665–670

    PubMed  CAS  Google Scholar 

  6. Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Koojimans M, Clanet M, Radue EW, Kappos L; European Interferon Beta-1A in Relapsing MS Dose Comparison Trial Study Group (2003) Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. Arch Neurol 60:1736–1739

    Article  PubMed  Google Scholar 

  7. Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Koojimans M, Clanet M, Radue EW, Kappos L; European Interferon Beta-1A in Relapsing MS Dose Comparison Trial Study Group (2005) Rate of brain atrophy in relapsing MS decreases during treatment with IFN beta-1a. Neurology 64:236–240

    PubMed  CAS  Google Scholar 

  8. Hardmeier M, Radue EW, Kappos L (2005) Short-term brain atrophy changes in relapsing-remitting multiple sclerosis (Letter to the Editor, article by Zivadinov et al). J Neurol Sci 231:101

    Article  PubMed  CAS  Google Scholar 

  9. Kalkers NF, Ameziane N, Bot JC et al (2002) Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol 59:1572–1576

    Article  PubMed  Google Scholar 

  10. Losseff NA, Kingsley DP, McDonald WI et al (1996) Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler 1:218–222

    PubMed  CAS  Google Scholar 

  11. Miller DH, Barkhof F, Frank JA (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695

    Article  PubMed  Google Scholar 

  12. Paolillo A, Pozzilli C, Gasperini C et al (2000) Brain atrophy in relapsing-remitting multiple sclerosis: relationship with “black holes,” disease duration and clinical disability. J Neurol Sci 174:85–91

    Article  PubMed  CAS  Google Scholar 

  13. Rovaris M, Comi G, Rocca MA et al (2001) Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain 124:1803–1812

    Article  PubMed  CAS  Google Scholar 

  14. Rudick RA (2004) Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis J Neuroimaging 14(3 Suppl):S54–S64

    Google Scholar 

  15. Zivadinov R, Bakshi R (2004) Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9:647–664

    Article  PubMed  Google Scholar 

  16. Zivadinov R, Zorzon M (2004) Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature J Neuroimaging 12:302–309

    Article  Google Scholar 

  17. Zivadinov R, Sepcic J, Nasuelli D et al (2001) A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70:773–780

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Hassan Abad Square, Tehran, Iran, Islamic Republic of

    Mohammad Ali Sahraian

  2. Head of Department of Neuroradiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland

    Ernst-Wilhelm Radue

Authors
  1. Mohammad Ali Sahraian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernst-Wilhelm Radue
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Head of Department of Neuroradiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland

    Ernst-Wilhelm Radü

  2. Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Hassan Abad Square, Tehran, Iran, Islamic Republic of

    Mohammad Ali Sahraian

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sahraian, M., Radue, EW. (2007). Multiple Sclerosis and Brain Atrophy. In: Radü, EW., Sahraian, M. (eds) MRI Atlas of MS Lesions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71372-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71372-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71371-5

  • Online ISBN: 978-3-540-71372-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation